BR112016023046A8 - kit compreendendo anticorpos e agentes redutores - Google Patents

kit compreendendo anticorpos e agentes redutores

Info

Publication number
BR112016023046A8
BR112016023046A8 BR112016023046A BR112016023046A BR112016023046A8 BR 112016023046 A8 BR112016023046 A8 BR 112016023046A8 BR 112016023046 A BR112016023046 A BR 112016023046A BR 112016023046 A BR112016023046 A BR 112016023046A BR 112016023046 A8 BR112016023046 A8 BR 112016023046A8
Authority
BR
Brazil
Prior art keywords
antibodies
kit
reducing agents
detecting
methods
Prior art date
Application number
BR112016023046A
Other languages
English (en)
Inventor
l murray David
R Barnidge David
R Mills John
Dasari Surendra
Original Assignee
Mayo Found Medical Education & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Found Medical Education & Res filed Critical Mayo Found Medical Education & Res
Publication of BR112016023046A8 publication Critical patent/BR112016023046A8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G01N30/724—Nebulising, aerosol formation or ionisation
    • G01N30/7266—Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7095—Inflammation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Dispersion Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

kit compreendendo anticorpos e agentes redutores o presente documento refere-se a métodos para detecção e quantificação de cadeias pesadas e leves de imunoglobulina usando técnicas de espectrometria de massa.
BR112016023046A 2014-04-04 2015-04-03 kit compreendendo anticorpos e agentes redutores BR112016023046A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461975524P 2014-04-04 2014-04-04
PCT/US2015/024379 WO2015154052A1 (en) 2014-04-04 2015-04-03 Isotyping immunoglobulins using accurate molecular mass

Publications (1)

Publication Number Publication Date
BR112016023046A8 true BR112016023046A8 (pt) 2021-05-11

Family

ID=54241354

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016023046A BR112016023046A8 (pt) 2014-04-04 2015-04-03 kit compreendendo anticorpos e agentes redutores

Country Status (8)

Country Link
US (4) US10267806B2 (pt)
EP (1) EP3126826B1 (pt)
JP (2) JP6759104B2 (pt)
AU (2) AU2015240454B2 (pt)
BR (1) BR112016023046A8 (pt)
CA (1) CA2944767C (pt)
ES (1) ES2861600T3 (pt)
WO (1) WO2015154052A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3729958T3 (da) * 2013-03-15 2023-08-07 Mayo Found Medical Education & Res Identificering og overvågning af monoklonale immunoglobuliner ved hjælp af molekylmasse
CA2944767C (en) 2014-04-04 2022-07-12 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
US10690676B2 (en) 2014-07-29 2020-06-23 Mayo Roundation for Medical Education and Research Quantifying monoclonal antibody therapeutics by LC-MS/MS
WO2017053932A1 (en) 2015-09-24 2017-03-30 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
CN116333124A (zh) * 2016-01-29 2023-06-27 索伦托药业有限公司 与pd-l1结合的抗原结合蛋白
GB201603291D0 (en) * 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
CN109863395B (zh) * 2016-09-07 2023-05-23 梅约医学教育与研究基金会 分子量法鉴定和监测裂解免疫球蛋白
GB2567793B (en) * 2017-04-13 2023-03-22 Micromass Ltd A method of fragmenting and charge reducing biomolecules
GB201708262D0 (en) * 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease
US20200271663A1 (en) 2017-09-13 2020-08-27 Mayo Foundation For Medical Education And Research Identification and monitoring of acid hydrolysis products of immunoglobulin heavy chains
WO2019055632A1 (en) * 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J
EP3681528A4 (en) 2017-09-13 2021-07-21 Mayo Foundation for Medical Education and Research IDENTIFICATION AND MONITORING OF THE APOPTOSIS INHIBITOR OF MACROPHAGES
GB201808529D0 (en) * 2018-05-24 2018-07-11 Binding Site Group Ltd Identification of immunoglobulins usong mass spectrometry
GB201906599D0 (en) 2019-05-10 2019-06-26 Binding Site Group Ltd Mass spectrometry calibrator
CA3139862A1 (en) 2019-05-10 2020-11-19 The Binding Site Group Limited Mass spectrometry calibrator
GB201915946D0 (en) 2019-11-01 2019-12-18 Binding Site Group Ltd Quantitation of immunoglobulins i n mass spectrometry
WO2021118353A1 (en) * 2019-12-11 2021-06-17 Erasmus University Medical Center Rotterdam Method for monitoring of deep remissions in multiple myeloma and other plasma cell dyscrasias
GB202007047D0 (en) 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls
GB202008887D0 (en) 2020-06-11 2020-07-29 Binding Site Group Ltd A method of identifying or characterising an immune response in a subject
WO2021258114A1 (en) * 2020-06-18 2021-12-23 Northwestern University Process for direct readout of immunoglobulins
GB202016822D0 (en) 2020-10-23 2020-12-09 Binding Site Group Ltd Quantitation of immunoglobulins in mass spectrometry
CN112326860B (zh) * 2020-10-30 2022-12-09 淄博高新技术产业开发区生物医药研究院 同时检测原料药或制剂中1,4-二氯丁烷和1-氯-4-羟基丁烷遗传毒性杂质的方法
US20240192223A1 (en) * 2021-06-10 2024-06-13 Mayo Foundation For Medical Education And Research Methods and materials for identifying and treating monoclonal and oligoclonal gammopathies
CN115684606B (zh) * 2022-10-21 2023-11-28 南方医科大学珠江医院 一种m蛋白检测的方法

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63139199A (ja) 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
US20030027216A1 (en) 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
US5846735A (en) 1996-04-18 1998-12-08 University Of Iowa Research Foundation Hepatitis C virus Fc-binding function
AU2001292312A1 (en) 2000-09-29 2002-04-08 Chugai Seiyaku Kabushiki Kaisha Method of analyzing antibody molecule structure
JP2005504263A (ja) 2001-02-01 2005-02-10 シファーゲン バイオシステムズ， インコーポレイテッド タンデム質量分析によるタンパク質同定、特徴付けおよび配列決定のための改良された方法
RU2004100112A (ru) 2001-06-06 2005-04-20 Канаг Диагностикс Аб (Se) Способ измерения отношения генной экспрессии ключевых генов
CA2468161A1 (en) 2001-11-29 2003-06-05 Thermo Finnigan Llc Polypeptide quantitation
EP1456667B2 (en) 2001-12-08 2010-01-20 Micromass UK Limited Method of mass spectrometry
US7267942B2 (en) 2003-03-24 2007-09-11 The University Of Hong Kong Diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS)
US7709610B2 (en) 2003-05-08 2010-05-04 Facet Biotech Corporation Therapeutic use of anti-CS1 antibodies
WO2005101017A1 (en) 2004-04-07 2005-10-27 Genentech, Inc. Mass spectrometry of antibody conjugates
EP2927322A1 (en) 2004-06-10 2015-10-07 Viventia Bio Inc. Tumor specific antibody
GB0501741D0 (en) 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
WO2006119435A2 (en) 2005-05-04 2006-11-09 Invitrogen Corporation Identification of cancer biomarkers and phosphorylated proteins
WO2006133420A2 (en) 2005-06-08 2006-12-14 Millennium Pharmaceuticals, Inc. Treatment of patients with cancer therapy
US20110177492A1 (en) 2005-06-16 2011-07-21 3M Innovative Properties Company Method of classifying chemically crosslinked cellular samples using mass spectra
JP2007024631A (ja) 2005-07-14 2007-02-01 Human Science Shinko Zaidan 同位体標識法
TWI338779B (en) 2005-07-21 2011-03-11 Academia Sinica Methods,compositions and systems for assaying at least one target analyte in a sample
US8080428B2 (en) 2006-04-28 2011-12-20 Singapore Health Services Pte Ltd. Investigation of mucosa dryness conditions
EP2013356B1 (en) 2006-05-02 2010-09-01 Genentech, Inc. Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry
CA2655685A1 (en) 2006-06-28 2008-01-03 Lineagen, Inc. Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions
AU2007284724B2 (en) 2006-08-10 2014-03-13 Millennium Pharmaceuticals, Inc. For the identification, assessment, and treatment of patients with cancer therapy
US20090203602A1 (en) 2006-09-01 2009-08-13 Cohava Gelber Compositions and methods for diagnosis and treatment of type 2 diabetes
WO2008033571A2 (en) 2006-09-15 2008-03-20 Memorial Sloan Kettering Cancer Center Methods of diagnosing, treating, or preventing plasma cell disorders
US7462489B2 (en) 2006-11-09 2008-12-09 Ley Klaus F Methods for identifying and analyzing biomarkers from plasma-derived microparticles
WO2008057083A1 (en) 2006-11-09 2008-05-15 Wyeth Methods of analyzing glycomolecules
ES2374403T3 (es) 2006-12-21 2012-02-16 Novartis Ag Cuantificación de anticuerpos.
GB0704764D0 (en) 2007-03-12 2007-04-18 Electrophoretics Ltd Isobarically labelled reagents and methods of their use
FI20075278A0 (fi) 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
US8501907B2 (en) 2007-08-10 2013-08-06 Janssen Biotech, Inc. Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
NZ582916A (en) 2007-08-10 2012-08-31 Centocor Ortho Biotech Inc Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
ES2622460T3 (es) 2007-09-26 2017-07-06 Ucb Biopharma Sprl Fusiones de anticuerpos con doble especificidad
CN101874207A (zh) 2007-11-22 2010-10-27 西福根有限公司 用于表征重组多克隆蛋白质的方法
WO2009100390A2 (en) 2008-02-08 2009-08-13 Mayo Foundation For Medical Education And Research Classifying amyloidosis
WO2009148528A2 (en) 2008-05-30 2009-12-10 Millennium Pharmaceuticals, Inc. Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
US20110151494A1 (en) * 2008-06-30 2011-06-23 H. Lee Moffit Cancer & Research Institute Methods and materials for monitoring myeloma using quantitative mass spectrometry
EP2389583A1 (en) 2009-01-22 2011-11-30 Ludwig Institute for Cancer Research, Ltd. Methods and compositions for diagnosis and treatment of malignant and non-malignant gammopathies
CA2750818A1 (en) 2009-01-27 2010-08-05 Proteogenix, Inc. Biomarkers for detection of neonatal sepsis in biological fluid
CA2750977A1 (en) 2009-02-09 2010-08-12 Roche Glycart Ag Immunoglobulin glycosylation pattern analysis
WO2010119295A1 (en) 2009-04-16 2010-10-21 Cambridge Enterprise Limited Biomarkers
GB0914535D0 (en) 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
JP5379616B2 (ja) 2009-09-09 2013-12-25 株式会社日立製作所 粥状硬化性動脈硬化のマーカー因子と用途
WO2011072197A2 (en) 2009-12-11 2011-06-16 Purdue Research Foundation Detection of oxidized polypeptides
GB0922240D0 (en) 2009-12-21 2010-02-03 Cambridge Entpr Ltd Biomarkers
WO2011082435A1 (en) 2010-01-04 2011-07-07 Lineagen, Inc. Biomarkers of lung function
US8643274B2 (en) 2010-01-26 2014-02-04 Scinopharm Taiwan, Ltd. Methods for Chemical Equivalence in characterizing of complex molecules
JP5337096B2 (ja) 2010-04-28 2013-11-06 株式会社日立製作所 動脈硬化の評価法
GB201008340D0 (en) 2010-05-19 2010-07-07 Cambridge Entpr Ltd Biomarkers
SG188527A1 (en) 2010-09-21 2013-04-30 Proteomics Internat Pty Ltd Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
GB201018056D0 (en) 2010-10-26 2010-12-08 Cambridge Entpr Ltd Biomarkers
US20130273055A1 (en) 2010-11-16 2013-10-17 Eric Borges Agents and methods for treating diseases that correlate with bcma expression
JP5066599B2 (ja) 2010-11-17 2012-11-07 株式会社日立製作所 動脈硬化病変を評価するための方法及びキット
ES2530175T3 (es) 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
KR20140024914A (ko) 2011-04-29 2014-03-03 셀진 코포레이션 예측인자로 세레브론을 사용하는 암 및 염증성 질환의 치료를 위한 방법
CA2833212C (en) 2011-05-12 2020-06-09 Genentech, Inc. Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides
EP2732423A4 (en) 2011-07-13 2014-11-26 Multiple Myeloma Res Foundation Inc METHOD FOR DETECTING AND DISTRIBUTING DATA
CA2848520C (en) 2011-09-29 2019-11-26 Seattle Genetics, Inc. Intact mass determination of protein conjugated agent compounds
GB2495113A (en) 2011-09-29 2013-04-03 Bioinvent Int Ab Anti-ICAM-1 antibody for treating multiple-myeloma-related disorders
EP2783214A2 (en) 2011-11-23 2014-10-01 The Board of Regents of The University of Texas System Proteomic identification of antibodies
AU2012359020B2 (en) * 2011-12-19 2017-04-13 The Washington University Methods for diagnosing Alzheimer's disease
GB201203938D0 (en) 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
CA2872540A1 (en) 2012-05-10 2013-11-14 Zymeworks Inc. Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain
US20150204884A1 (en) 2012-06-01 2015-07-23 Momenta Pharmaceuticals, Inc. Methods of evaluating and making biologics
WO2013185180A1 (en) 2012-06-14 2013-12-19 Central Adelaide Local Health Network Inc. Method for identifying a diagnostic biomarker for an antibody of interest
US9502225B2 (en) 2012-06-20 2016-11-22 The University Of North Carolina At Chapel Hill Integrated sample processing for electrospray ionization devices
US20150219665A1 (en) 2012-09-10 2015-08-06 Koninklijke Philips N.V. Analysis of saliva proteome for biomarkers of gingivitis and periodontitis using ft-icr-ms/ms
WO2014078374A2 (en) 2012-11-13 2014-05-22 Presage Biosciences, Inc. Methods for multiplexed drug evaluation
US20140186332A1 (en) 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
US20150352230A1 (en) 2013-01-11 2015-12-10 The Regents Of The University Of Michigan Synthesis and isolation of dendrimer based imaging systems
CN103217489B (zh) 2013-01-15 2016-03-09 珠海市丽珠单抗生物技术有限公司 一种测定蛋白纯化工艺过程中样品的糖基化和末端修饰情况的方法
WO2014121031A1 (en) 2013-01-31 2014-08-07 Excelimmune, Inc. Characterization of antibody mixtures by mass spectrometry
US20160033511A1 (en) 2013-03-13 2016-02-04 Creatics Llc Methods and compositions for detecting pancreatic cancer
WO2014140995A2 (en) 2013-03-15 2014-09-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
DK3729958T3 (da) 2013-03-15 2023-08-07 Mayo Found Medical Education & Res Identificering og overvågning af monoklonale immunoglobuliner ved hjælp af molekylmasse
WO2015038665A1 (en) 2013-09-11 2015-03-19 University Of Southern California A composition of stem cells having highly expressed fas ligand
GB201316744D0 (en) 2013-09-20 2013-11-06 Genovis Ab Method
WO2015120036A1 (en) 2014-02-04 2015-08-13 University Of Virginia Patent Foundation Compositions and methods for analysis of protein sequences and post-translational modifications
US10175242B2 (en) 2014-02-28 2019-01-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Personalized myeloma detection
US9618524B2 (en) 2014-03-26 2017-04-11 Plaxgen Inc. Method, composition, isolation and identification of a plaque particle and related biomarker
CA2944767C (en) 2014-04-04 2022-07-12 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
EP2975401B1 (en) 2014-07-18 2019-12-25 Hexal AG Improved method of mapping glycans of glycoproteins in serum samples
US10690676B2 (en) 2014-07-29 2020-06-23 Mayo Roundation for Medical Education and Research Quantifying monoclonal antibody therapeutics by LC-MS/MS
WO2016134365A1 (en) 2015-02-20 2016-08-25 The Johns Hopkins University Biomarkers of myocardial injury
US10338039B2 (en) 2015-03-09 2019-07-02 Shimadzu Corporation Method for detecting monoclonal antibody using mass spectrometry
KR20240093813A (ko) 2015-04-24 2024-06-24 제넨테크, 인크. 다중특이적 항원-결합 단백질
US20170044608A1 (en) 2015-07-17 2017-02-16 Allele Biotechnology & Pharmaceuticals, Inc. Methods of selecting antibodies and antibody fragments
JP6666916B2 (ja) 2015-08-06 2020-03-18 積水メディカル株式会社 腎疾患の検査方法
WO2017053932A1 (en) 2015-09-24 2017-03-30 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
DK3411389T3 (da) 2016-02-04 2021-06-21 Genovis Ab Nye streptokokproteaser
ES2942315T3 (es) 2016-02-25 2023-05-31 The Binding Site Group Ltd Anticuerpos
US20190154692A1 (en) 2016-04-12 2019-05-23 Biocrypton Inc. Compositions and methods for screening, monitoring and treating gastrointestinal diseases
US10309968B2 (en) 2016-05-18 2019-06-04 Bioinformatics Solutions Inc. Methods and systems for assembly of protein sequences
US11067583B2 (en) 2016-05-25 2021-07-20 University Of Maryland, Baltimore Methods of making active antibodies from biological fluids
CN109863395B (zh) 2016-09-07 2023-05-23 梅约医学教育与研究基金会 分子量法鉴定和监测裂解免疫球蛋白
EP3681528A4 (en) 2017-09-13 2021-07-21 Mayo Foundation for Medical Education and Research IDENTIFICATION AND MONITORING OF THE APOPTOSIS INHIBITOR OF MACROPHAGES
US20200271663A1 (en) 2017-09-13 2020-08-27 Mayo Foundation For Medical Education And Research Identification and monitoring of acid hydrolysis products of immunoglobulin heavy chains
WO2019055632A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J

Also Published As

Publication number Publication date
AU2019268150B2 (en) 2020-08-27
AU2019268150A1 (en) 2019-12-12
AU2015240454A1 (en) 2016-11-24
CA2944767C (en) 2022-07-12
US20200341003A1 (en) 2020-10-29
WO2015154052A1 (en) 2015-10-08
JP2021021734A (ja) 2021-02-18
AU2015240454B2 (en) 2019-08-22
JP6951527B2 (ja) 2021-10-20
EP3126826B1 (en) 2020-12-16
EP3126826A4 (en) 2019-01-02
ES2861600T3 (es) 2021-10-06
US10753945B2 (en) 2020-08-25
CA2944767A1 (en) 2015-10-08
US20200003784A1 (en) 2020-01-02
EP3126826A1 (en) 2017-02-08
US10267806B2 (en) 2019-04-23
JP2017513004A (ja) 2017-05-25
US20230243845A1 (en) 2023-08-03
US11604196B2 (en) 2023-03-14
US20170023584A1 (en) 2017-01-26
JP6759104B2 (ja) 2020-09-23

Similar Documents

Publication Publication Date Title
BR112016023046A8 (pt) kit compreendendo anticorpos e agentes redutores
CL2018000778A1 (es) Proteínas de unión a pd-1 y métodos para usarlas
HK1255589A1 (zh) Cd70及cd3抗體構築體
DK3455257T3 (da) Anti-pd-l1-antistoffer
DK3411404T3 (da) Psma- og cd3-bispecifikke t-celleinddragende antistofkonstruktioner
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
DK3332006T5 (da) Hidtil ukendte anti-PD-L1-antistoffer
DK3177643T3 (da) Bispecifikke T-celle-aktiverende antigenbindende molekyler
BR112017011932A8 (pt) Anticorpos direcionados a receptor acoplado a proteína g e métodos de uso
CU20160118A7 (es) Moléculas de anticuerpo que se unen a tim-3
CO7151527A2 (es) Anticuerpos anti-cd79 b e inmunoconjugados
BR112017011914A2 (pt) ?antígeno de maturação de célula b de direcionamento de anticorpos e métodos de uso?
CR20150482A (es) Anticuerpos e inmunoconjugados anti-b7-h4
DK3182999T3 (da) Anti-lag3-antistoffer og antigenbindingsfragmenter
BR112016022658A2 (pt) anticorpos anti-ox40 e métodos de uso
BR112015032224A2 (pt) anticorpos anti-fcrh5
DK2941633T3 (da) Assayapparater, fremgangsmåder og reagenser
DK3645571T3 (da) Her3-antigen-bindende molekyler
EP3153858A4 (en) Method for eliminating prozone phenomenon in immunoassay reagent
BR112016018313A2 (pt) moléculas de ligação multiespecíficas iga
NZ631098A (en) Anti-hepcidin antibodies and uses thereof
BR112016014731A2 (pt) Anticorpos anti-baff
DK3092003T3 (da) Hidtil ukendt anti-netrin-1-antistof
EP3270152A4 (en) KIT FOR SAMPLE PREPARATION FOR THE DETECTION OF MONOCLONAL ANTIBODIES
DK3154587T3 (da) Konjugater omfattende et anti-egfr1-antistof

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: G01N 30/72 , G01N 33/48

Ipc: G01N 33/68 (2006.01), G01N 30/72 (2006.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]